Mosquito-borne Plasmodium infection; P. falciparum causes most morbidity and severe disease — empiric treatment guided by species and severity.
Also known as: malaria, Plasmodium falciparum, Plasmodium vivax, P. ovale, P. malariae, P. knowlesi
Overview
Parasitic illness caused by Plasmodium protozoa transmitted by female Anopheles mosquitoes. Five species infect humans: P. falciparum, P. vivax, P. ovale, P. malariae, and P. knowlesi (Southeast Asia, zoonotic). P. falciparum and P. knowlesi cause the most severe disease.
Epidemiology
Worldwide ~240 million cases and ~600,000 deaths annually (WHO 2022), predominantly children under 5 in sub-Saharan Africa. ~2,000 imported US cases yearly. Sub-Saharan Africa: P. falciparum dominant. Asia/Americas: P. vivax common.
Try two board-style Malaria questions
Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.
Question 1Infectious DiseaseMedium
A 55-year-old man presents 10 days after returning from a 3-week trip to sub-Saharan Africa. He reports 4 days of high fevers with chills and rigors occurring at irregular intervals, myalgias, and headache. He did not take malaria chemoprophylaxis. Exam shows temperature 39.5C and mild splenomegaly. Labs show thrombocytopenia (platelets 78 K/uL). Giemsa-stained thick and thin blood smears reveal multiple ring-form trophozoites within single erythrocytes and crescent-shaped (banana-shaped) gametocytes. Which of the following is the most likely diagnosis?
APlasmodium ovale
BPlasmodium knowlesi
CPlasmodium malariae
DPlasmodium vivax
EPlasmodium falciparum
Reveal answer & full explanation
Correct answer: E — Plasmodium falciparum
APlasmodium ovale
BPlasmodium knowlesi
CPlasmodium malariae
DPlasmodium vivax
EPlasmodium falciparum✓
Why Plasmodium falciparum is correct
Smear shows multiple ring-form trophozoites within a single erythrocyte — suggestive of high-density falciparum parasitemia, though not specific (multiply infected RBCs also occur with P. knowlesi and occasionally with other species)
Crescent-shaped (banana-shaped) gametocytes are pathognomonic for P. falciparum
P. falciparum is the most dangerous species and can cause cerebral malaria, acute respiratory distress syndrome (ARDS), and acute kidney injury (AKI)
Why the others are wrong
Plasmodium ovale — does not produce banana-shaped gametocytes; its gametocytes are round, and infected RBCs are enlarged and oval with fimbriated edges
Plasmodium malariae — does not produce banana-shaped gametocytes; it shows band-form trophozoites and rosette schizonts in normal-sized or small RBCs
Plasmodium vivax — does not produce banana-shaped gametocytes; its gametocytes are round, infected RBCs are enlarged with Schuffner dots, and it is uncommon in most of sub-Saharan Africa because most West and Central Africans are Duffy antigen-negative
Plasmodium knowlesi — it can also produce high parasitemia with multiple ring forms per erythrocyte, but it is a zoonotic macaque parasite acquired in Southeast Asia (especially Malaysian Borneo), not sub-Saharan Africa, and it does not produce banana-shaped gametocytes
Additional high-yield points
Treatment of uncomplicated chloroquine-resistant P. falciparum (CDC): artemether-lumefantrine, an artemisinin-based combination therapy (ACT), is the preferred option, given as an extended 5-day (10-dose) course since CDC's August 2026 update; atovaquone-proguanil is the alternative
Severe or cerebral P. falciparum: IV artesunate, which is superior to quinine per the AQUAMAT trial
P. falciparum is chloroquine-resistant in most of Africa and Asia
Question 2Infectious DiseaseMedium
A 34-year-old man presents with 5 days of fever, headache, and myalgias that began shortly after returning from a 3-week trip to rural Nigeria, where he did not take chemoprophylaxis. Temperature is 39.4°C (102.9°F), and he appears fatigued with mild scleral icterus and splenomegaly. Laboratory studies show hemoglobin of 10.1 g/dL, platelets of 88,000/µL, and an elevated LDH. Which of the following is the most appropriate next diagnostic test?
AADAMTS13 activity level
BBlood plus stool cultures
CThick and thin blood smears
DHIV-1 RNA quantitative test
EDengue NS1 with IgM serology
Reveal answer & full explanation
Correct answer: C — Thick and thin blood smears
AADAMTS13 activity level
BBlood plus stool cultures
CThick and thin blood smears✓
DHIV-1 RNA quantitative test
EDengue NS1 with IgM serology
Why Thick and thin blood smears is correct
Fever in a traveler returning from sub-Saharan Africa is malaria until proven otherwise, and this vignette (fever, thrombocytopenia, hemolytic anemia with elevated LDH, scleral icterus, splenomegaly) is classic for Plasmodium infection.
Giemsa-stained thick and thin smears are the diagnostic gold standard: the thick smear maximizes sensitivity for detecting parasites, while the thin smear allows species identification and quantitation of parasitemia, which guides severity classification and therapy.
Smears must be obtained urgently, within hours rather than days, and, if negative, repeated every 12-24 hours for a total of 3 sets before malaria can be excluded, because parasitemia fluctuates with the erythrocytic cycle. A rapid antigen test can supplement but does not replace the smear.
Why the others are wrong
Blood plus stool cultures: This is the workup for typhoid fever, which can mimic malaria with fever and abdominal symptoms but classically shows stepwise fever, relative bradycardia, and rose spots; cultures do not detect a blood-borne parasite and would delay the time-critical malaria diagnosis.
Dengue NS1 with IgM serology: Dengue is co-endemic and also causes fever and thrombocytopenia, but it features retro-orbital pain and rash rather than hemolytic anemia, jaundice, and splenomegaly; pursuing it first risks missing potentially fatal falciparum malaria.
HIV-1 RNA quantitative test: Acute HIV is tested when there is a recent high-risk exposure, which is absent here; it does not explain the hemolytic picture and is not the priority in a febrile returning traveler from an endemic area.
ADAMTS13 activity level — fever with thrombocytopenia, hemolytic anemia, and an elevated LDH can suggest thrombotic thrombocytopenic purpura, but malaria causes the same combination, and splenomegaly after travel to rural Nigeria without chemoprophylaxis makes malaria the diagnosis to exclude first; ADAMTS13 activity cannot detect a blood-borne parasite, and even when TTP is suspected a peripheral smear is examined first, so ordering ADAMTS13 instead would delay the time-critical smear.
That's 2. Get 7,700+ more.
Unlock the full FirstPassPA bank: 7,700+ board-style questions, flashcards, and an AI tutor that explains every answer. Your 7-day free trial includes everything, and there's no credit card required.
You've read your 2 free diagnosis previews. Create your free account to unlock the full Malaria outline — plus all 514 diagnoses, 7,700+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.
Inadequate vector avoidance (no bed nets, no DEET, dawn/dusk exposure)
Pregnancy (severe malaria more common; placental sequestration)
Asplenia (poor parasite clearance)
Sickle cell trait protects against severe P. falciparum
Pathophysiology
Sporozoites injected by mosquito infect hepatocytes (exoerythrocytic stage). After 1-2 weeks, merozoites release into the bloodstream and invade RBCs (erythrocytic stage). Repeated cycles of RBC rupture cause cyclic fever paroxysms. P. falciparum infects RBCs of all ages and causes cytoadherence to endothelium → microvascular sequestration → cerebral malaria, ARDS, AKI, severe anemia. P. vivax and P. ovale form dormant liver hypnozoites that can reactivate months to years later.
Clinical presentation
Symptoms
Incubation: P. falciparum 7-30 days; P. vivax/ovale weeks to months (or years for relapse)
Cyclic fever paroxysms (cold stage → hot stage → diaphoretic stage); classic 48-hour cycle (vivax, ovale) or 72-hour (malariae); P. falciparum often continuous or irregular
Severe malaria (P. falciparum): impaired consciousness, seizures (cerebral malaria), respiratory distress, jaundice, oliguria, severe anemia, hypoglycemia, shock
Signs / physical exam
Fever (may be high), pallor, hepatosplenomegaly, jaundice
Tachypnea (compensatory for metabolic acidosis)
Petechiae rare (unlike dengue)
Coma, decerebrate posturing in cerebral malaria
Classic findings
A returning traveler from sub-Saharan Africa with cyclic fevers, thrombocytopenia, and elevated LDH — malaria until proven otherwise. Severe disease in non-immune travelers can present with shock, AKI, and ARDS.
Acute HIV — Recent high-risk exposure; RNA viral load
Babesiosis — Tick exposure (Ixodes), hemolytic anemia, intra-erythrocytic ring forms similar to P. falciparum; co-endemic in Northeast US
Influenza, other viral illnesses — Common; presents similarly early — always ask about travel
Diagnostic workup
Diagnostic criteria
Positive blood smear or RDT in a patient with consistent clinical syndrome. Severe malaria per WHO: impaired consciousness, prostration, multiple convulsions, acidosis, hypoglycemia, severe anemia (Hgb <7 adults), AKI, jaundice, pulmonary edema, abnormal bleeding, shock, hyperparasitemia (WHO >10%; CDC uses ≥5% for US patients).
Labs
Thick and thin blood smears (Giemsa) — thick for sensitivity, thin for species and parasitemia quantitation; if negative, repeat every 12-24 hours for a total of 3 sets before excluding diagnosis
Rapid diagnostic test (RDT, BinaxNOW Malaria) for antigen detection — useful in emergency settings
PCR for species confirmation (especially mixed infections)
G6PD activity before primaquine/tafenoquine (hemolysis risk)
CBC (hemolytic anemia, thrombocytopenia), CMP (AKI, transaminitis), bilirubin (indirect hyperbilirubinemia), glucose (hypoglycemia in severe disease), lactate, coagulation
Thin-smear species clues: P. falciparum — multiple small rings per RBC, normal-sized RBCs, banana/crescent-shaped gametocytes (pathognomonic); P. vivax/P. ovale — enlarged RBCs with Schüffner dots (ovale RBCs oval with fimbriated edges); P. malariae — band-form trophozoites, rosette schizonts; Babesia (mimic) — Maltese-cross tetrads, no pigment or gametocytes
Imaging
CXR if pulmonary symptoms (rule out ARDS)
CT/MRI brain if cerebral malaria features
Diagnostic algorithm
Species
Periodicity
Hypnozoite?
Severe Disease?
First-line Therapy
P. falciparum
Irregular / 36-48 h
No
Yes (most severe)
Artemether-lumefantrine; IV artesunate if severe
P. vivax
48 h (tertian)
Yes
Rare
Chloroquine + primaquine (or tafenoquine)
P. ovale
48 h (tertian)
Yes
Rare
Chloroquine + primaquine
P. malariae
72 h (quartan)
No
Rare
Chloroquine
P. knowlesi
24 h
No
Yes
Artemisinin-based therapy
Plasmodium species comparison: clinical features and first-line treatment.
Treatment
First-line
Uncomplicated P. falciparum (or unidentified species, chloroquine-resistant areas):
• Artemether-lumefantrine (Coartem) PO with fatty food, extended 5-day (10-dose) course per CDC August 2026 (previously 3 days) — preferred US treatment for uncomplicated falciparum
• Atovaquone-proguanil (Malarone) PO × 3 days
• Quinine sulfate + doxycycline (or tetracycline/clindamycin) × 7 days
Severe malaria:
• IV artesunate 2.4 mg/kg at 0, 12, and 24 h, then daily while parasitemia >1% or unable to take PO — FDA-approved and commercially available (hospital stock, distributor, or nearby hospital; CDC no longer supplies it); if it is delayed, give interim oral artemether-lumefantrine; transition to oral once parasitemia ≤1% and tolerating PO
• Followed by full oral course: artemether-lumefantrine (extended 5-day, 10-dose course for P. falciparum) or atovaquone-proguanil
Chloroquine-sensitive infections (P. malariae, P. ovale, P. vivax from chloroquine-sensitive areas):
• Chloroquine phosphate PO × 3 days
Hypnozoite eradication (P. vivax, P. ovale):
• Primaquine 30 mg base daily × 14 days (after G6PD testing); single-dose tafenoquine 300 mg alternative
Second-line / adjunct
Chemoprophylaxis options for travelers:
• Atovaquone-proguanil daily (starting 1-2 days before travel, continuing 7 days after return)
• Doxycycline daily (1-2 days before, continuing 4 weeks after — also covers leptospirosis, rickettsial illness)
• Tafenoquine weekly (3 days before, weekly during, single dose after; requires G6PD testing)
Exchange transfusion historically considered for hyperparasitemia (>10%) — no longer routinely recommended with IV artesunate
Complications
Cerebral malaria (impaired consciousness, seizures, death) — leading cause of mortality
Severe hemolytic anemia, blackwater fever (massive intravascular hemolysis with hemoglobinuria)
ARDS, AKI requiring dialysis
Hypoglycemia (especially in pregnancy, children, quinine-treated patients)
Splenic rupture (especially P. vivax)
Relapse months to years later (P. vivax, P. ovale)
Adverse fetal outcomes in pregnancy (low birth weight, prematurity, stillbirth)
PANCE pearls
Fever in a returned traveler is malaria until proven otherwise — obtain smears within hours, not days.
Always check G6PD before primaquine or tafenoquine (severe hemolysis if deficient).
IV artesunate is the standard for severe malaria worldwide; in the US it is FDA-approved and commercially available (CDC no longer supplies it) — if it is not immediately on hand, start interim oral artemether-lumefantrine while it is obtained.
Pregnant patients with malaria are at extreme risk — early specialist involvement; quinine + clindamycin historically used in first trimester though artemether-lumefantrine increasingly used.
P. vivax and P. ovale hypnozoites require primaquine/tafenoquine for radical cure to prevent relapse months later.
References
WHO 2026 — WHO guidelines for malaria (consolidated living guideline). Geneva: World Health Organization; version of 10 September 2026
CDC 2026 — Clinical Guidance: Malaria Diagnosis and Treatment in the U.S. — Treatment of Uncomplicated Malaria and Treatment of Severe Malaria (updated August 17, 2026)
AQUAMAT — Dondorp et al., Artesunate versus quinine in the treatment of severe falciparum malaria in African children (Lancet 2010)
Practice Infectious Disease questions on FirstPassPA
Turn this outline into retention. 7,700+ board-style questions with an AI tutor that explains every answer — free to start, no card required.
Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.